CA2214143A1 - Compositions de combinaison contenant benazeprile ou benazeprilat et valsartane - Google Patents
Compositions de combinaison contenant benazeprile ou benazeprilat et valsartane Download PDFInfo
- Publication number
- CA2214143A1 CA2214143A1 CA002214143A CA2214143A CA2214143A1 CA 2214143 A1 CA2214143 A1 CA 2214143A1 CA 002214143 A CA002214143 A CA 002214143A CA 2214143 A CA2214143 A CA 2214143A CA 2214143 A1 CA2214143 A1 CA 2214143A1
- Authority
- CA
- Canada
- Prior art keywords
- active ingredient
- valsartan
- composition according
- ingredient component
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
L'invention se rapporte à des compositions de combinaison pharmaceutique pour le traitement de l'hypertension, l'insuffisante cardiaque globale et l'insuffisance rénale, comportant (1) le bénazéprile inhibiteur de ACE de formule (I) ou le bénazéprilat de formule (II) ou un de leurs sels pharmaceutiquement acceptables, et la valsartane antagoniste AT¿1? de formule (III) ou un de leurs sels pharmaceutiquement acceptables, ainsi que les méthodes de traitement de l'hypertension, de l'insuffisance cardiaque globale et de l'insuffisance rénale.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1012/95 | 1995-04-07 | ||
CH101295 | 1995-04-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2214143A1 true CA2214143A1 (fr) | 1996-10-10 |
Family
ID=4200393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002214143A Abandoned CA2214143A1 (fr) | 1995-04-07 | 1996-04-02 | Compositions de combinaison contenant benazeprile ou benazeprilat et valsartane |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0820302A1 (fr) |
JP (1) | JPH11503139A (fr) |
KR (1) | KR19980703647A (fr) |
CN (1) | CN1181019A (fr) |
AU (1) | AU5399096A (fr) |
BR (1) | BR9604818A (fr) |
CA (1) | CA2214143A1 (fr) |
CZ (1) | CZ313897A3 (fr) |
HU (1) | HUP9801593A2 (fr) |
MX (1) | MX9707683A (fr) |
NO (1) | NO974400L (fr) |
PL (1) | PL322529A1 (fr) |
SK (1) | SK133897A3 (fr) |
TR (1) | TR199701121T1 (fr) |
WO (1) | WO1996031234A1 (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11508894A (ja) * | 1995-06-30 | 1999-08-03 | メルク エンド カンパニー インコーポレーテッド | Ace阻害剤とaii拮抗薬を用いる腎疾患の治療方法 |
CN101011390A (zh) | 1999-01-26 | 2007-08-08 | 诺瓦提斯公司 | 血管紧张素ⅱ受体拮抗剂在治疗急性心肌梗塞中的应用 |
RU2298418C2 (ru) * | 2000-04-12 | 2007-05-10 | Новартис Аг | Комбинация по меньшей мере двух соединений, выбранных из групп антагонистов at1-рецептора или ингибиторов асе (ангиотензинпревращающий фермент), или ингибиторов hmg-coa-редуктазы (бета-гидрокси-бета-метилглутарил-кофермент-а-редуктаза) |
DK1313714T3 (da) | 2000-07-19 | 2008-12-15 | Novartis Ag | Valsartansalte |
JP2004520268A (ja) * | 2000-08-22 | 2004-07-08 | ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト | アンギオテンシンii拮抗剤とアンギオテンシンi変換酵素阻害剤とを含有する医薬組成物 |
GB0020691D0 (en) * | 2000-08-22 | 2000-10-11 | Boehringer Ingelheim Pharma | Pharmaceutical combination |
WO2002049645A1 (fr) * | 2000-12-18 | 2002-06-27 | Novartis Ag | Combinaison therapeutique d'amlodipine et de benazepril |
US6869970B2 (en) * | 2002-02-04 | 2005-03-22 | Novartis Ag | Crystalline salt forms of valsartan |
CN100377744C (zh) * | 2002-07-05 | 2008-04-02 | 安徽省生物医学研究所 | 一种预测acei类降压药药效的复方药 |
EP1578360A4 (fr) * | 2002-08-28 | 2009-10-21 | Curis Inc | Administration conjointe de morphogenes et d'inhibiteurs de conversion de l'enzyme de l'angiotensine pour le traitement de l'insuffisance renale chronique |
EP1908469A1 (fr) * | 2006-10-06 | 2008-04-09 | Boehringer Ingelheim Vetmedica Gmbh | Antagonistes du récepteur de l'angiotensine II pour traiter des désordres sistémiques des chats |
CN101869710A (zh) * | 2009-04-24 | 2010-10-27 | 北京奥萨医药研究中心有限公司 | 降压药物组合物 |
SG176585A1 (en) | 2009-05-20 | 2012-01-30 | Boehringer Ingelheim Vetmed | Pharmaceutical oral telmisartan solution |
US20110009347A1 (en) | 2009-07-08 | 2011-01-13 | Yin Liang | Combination therapy for the treatment of diabetes |
CN113144204A (zh) * | 2014-01-31 | 2021-07-23 | 詹森药业有限公司 | 用于治疗和预防肾病和脂肪肝病的方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2081564C (fr) * | 1990-05-11 | 1998-02-03 | Anthony Andrea Fossa | Compositions et methodes therapeutiques synergiques |
EP0629408A1 (fr) * | 1993-06-16 | 1994-12-21 | LABORATOIRES MERCK, SHARP & DOHME-CHIBRET | Combination d'inhibiteurs ACE et d'antagonistes AII |
-
1996
- 1996-04-02 PL PL96322529A patent/PL322529A1/xx unknown
- 1996-04-02 WO PCT/EP1996/001440 patent/WO1996031234A1/fr not_active Application Discontinuation
- 1996-04-02 CA CA002214143A patent/CA2214143A1/fr not_active Abandoned
- 1996-04-02 JP JP8529972A patent/JPH11503139A/ja active Pending
- 1996-04-02 CN CN96193111A patent/CN1181019A/zh active Pending
- 1996-04-02 MX MX9707683A patent/MX9707683A/es unknown
- 1996-04-02 TR TR97/01121T patent/TR199701121T1/xx unknown
- 1996-04-02 CZ CZ973138A patent/CZ313897A3/cs unknown
- 1996-04-02 BR BR9604818A patent/BR9604818A/pt not_active Application Discontinuation
- 1996-04-02 SK SK1338-97A patent/SK133897A3/sk unknown
- 1996-04-02 EP EP96910948A patent/EP0820302A1/fr not_active Withdrawn
- 1996-04-02 HU HU9801593A patent/HUP9801593A2/hu unknown
- 1996-04-02 AU AU53990/96A patent/AU5399096A/en not_active Abandoned
- 1996-04-02 KR KR1019970707046A patent/KR19980703647A/ko not_active Application Discontinuation
-
1997
- 1997-09-23 NO NO974400A patent/NO974400L/no unknown
Also Published As
Publication number | Publication date |
---|---|
JPH11503139A (ja) | 1999-03-23 |
SK133897A3 (en) | 1998-02-04 |
PL322529A1 (en) | 1998-02-02 |
EP0820302A1 (fr) | 1998-01-28 |
BR9604818A (pt) | 1998-06-09 |
CN1181019A (zh) | 1998-05-06 |
NO974400D0 (no) | 1997-09-23 |
WO1996031234A1 (fr) | 1996-10-10 |
CZ313897A3 (cs) | 1998-01-14 |
TR199701121T1 (xx) | 1998-03-21 |
KR19980703647A (ko) | 1998-12-05 |
NO974400L (no) | 1997-09-23 |
AU5399096A (en) | 1996-10-23 |
MX9707683A (es) | 1997-12-31 |
HUP9801593A2 (hu) | 1999-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6373931B2 (ja) | 循環器系疾患のためのレニン阻害剤を含む相乗的組合せ剤 | |
EP1467728B1 (fr) | Compositions pharmaceutiques a base de valsartan et d'inhibiteurs nep | |
RU2316318C2 (ru) | Фармацевтическая композиция, включающая ингибитор ренина, блокатор кальциевых каналов и диуретик | |
US8404744B2 (en) | Methods of treatment and pharmaceutical composition | |
CA2214143A1 (fr) | Compositions de combinaison contenant benazeprile ou benazeprilat et valsartane | |
JP2005532330A5 (fr) | ||
WO2007106708A2 (fr) | Combinaison de composes organiques | |
Morganti et al. | Aliskiren: the first direct renin inhibitor available for clinical use | |
EA009983B1 (ru) | Лекарственное средство для профилактики и лечения артериосклероза и гипертензии | |
US20040259925A1 (en) | Pharmaceutical compositions and methds for the prevention or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases | |
CA2513281C (fr) | Combinaison pharmaceutique pour prevenir ou soigner des maladies cardio-vasculaires, cardio-pulmonaires, pulmonaires ou renales | |
EP1146872B1 (fr) | Utilisation des antagonistes du recepteur d'angiotensine ii dans le traitement de l'infarctus aigu du myocarde | |
US6767905B2 (en) | Use of angiotensin II receptor antagonists for treating acute myocardial infarction | |
KR20230006884A (ko) | 뇌 아미노펩티다제 a 억제제, 이뇨제, 및 전신 레닌-안지오텐신 시스템의 차단제를 포함하는 약학 병용물 | |
ZA200503809B (en) | Pharmaceutical combination for the prophylaxis or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases | |
AU2007237280A1 (en) | Pharmaceutical combination of Angiotensin II antagonists and Angiotensin I converting enzyme inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |